发明名称 |
MIC-1 fusion proteins and uses thereof |
摘要 |
The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds. |
申请公布号 |
US9272019(B2) |
申请公布日期 |
2016.03.01 |
申请号 |
US201514742159 |
申请日期 |
2015.06.17 |
申请人 |
Novo Nordisk A/S |
发明人 |
Shaw Allan Christian;Helgstrand Charlotte;Sandrini Michael Paolo Bastner;Joergensen Sebastian Beck;Thoegersen Henning;Sass-Oerum Kristian;Hastrup Sven;Andersen Kim Vilbour |
分类号 |
A61K38/19;C07K14/765;C07K14/52;C07K14/00;A61K38/38 |
主分类号 |
A61K38/19 |
代理机构 |
|
代理人 |
Lum Leon Y. |
主权项 |
1. A fusion protein of formula (I):
A-B—C (I), wherein A is human serum albumin or a functional variant thereof; B is a peptide linker having the amino acid sequence of SEQ ID NO:9; and C is a MIC-1 protein or an analogue thereof, wherein the C-terminus of the human serum albumin or functional variant thereof is fused to the N-terminus of the peptide linker, and wherein the C-terminus of the peptide linker is fused to the N-terminus of the MIC-1 protein or analogue thereof. |
地址 |
Bagsvaerd DK |